U. Protzer et al., POST-INFANTILE GIANT-CELL HEPATITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS, Liver, 16(4), 1996, pp. 274-282
In post-infancy, multinucleated giant cell hepatitis is rare. Various
conditions and diseases associated with post-infantile giant cell hepa
titis have been described, but the pathogenesis remains unknown. In th
is paper we review the case reports of four patients (3 male, 1 female
; aged 22 to 32 years) with primary sclerosing cholangitis and autoimm
une hepatitis. The follow-up ranges from five to seven years. All pati
ents showed cholestasis and repeated elevation of hepatic transaminase
s. Patients with viral infections, metabolic disorders and toxic influ
ences were excluded. Histopathology of liver tissue in all four patien
ts revealed giant cell formation with up to 20 nuclei in 20-70% of all
hepatocytes. Post-infantile giant cell hepatitis was defined histopat
hologically. The clinical course of all four patients markedly improve
d after immunosuppressive treatment. Further improvement was observed
with the addition of ursodeoxycholic acid. Follow-up liver biopsies du
ring treatment showed reduced inflammation and a decreased number of g
iant cells. One patient, who initially was admitted to the hospital wi
th liver cirrhosis died five years later due to a sepsis. The clinical
course of the other three patients remained stable during the observa
tion period, and no progression of liver fibrosis was recorded as long
as immunosuppressive treatment was continued. Cholestasis and autoimm
unity seem to be two important mechanisms triggering hepatic giant cel
l formation in post-infancy. In the reported cases long-lasting choles
tasis in primary sclerosing cholangitis together with features of auto
immune hepatitis seem to have triggered the formation of syncytial hep
atic giant cells. (C) Munksgaard, 1996.